Eprinomectin and Moxidectin Resistance of Trichostrongyloids on a Goat Farm in Austria

• Main Authors: Hinney, B. (Author), Joachim, A. (Author), Kaiser, W. (Author), Krücken, J. (Author), Wiedermann, S. (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: anthelmintic resistance; Haemonchus contortus; macrocyclic lactones; Trichostrongylus
• Online Access: View Fulltext in Publisher

 Anthelmintic resistance (AR) of trichostrongyloids is widespread in Europe, but there is no up-to-date information on the spread of AR in caprine parasites in Austria. Eprinomectin (EPR) is currently the only anthelmintic drug of the macrocyclic lactones registered for goats in Europe. The aim of the present study was to gather information regarding the efficacy of anthelmintics against trichostrongyloids on a dairy goat farm in Austria with reported treatment failure of mac-rocyclic lactones and to determine the presence of different trichostrongyloid genera. Faecal egg count reduction tests (FECRT) using Mini-FLOTAC were performed with eprinomectin (EPR) and moxidectin (MOX). Egg count reduction, calculated with the R package egg-Counts, was 44% for EPR and 86% for MOX, confirming AR of trichostrongyloids for both compounds. The most fre-quently detected genus in larval cultures was Haemonchus, followed by Trichostrongylus. This is the first report of MOX resistance in caprine trichostrongyloids in Europe. Failure of EPR and MOX to control trichostrongyloid infections is a severe threat to dairy goat farming, since other compounds must not be applied in goats used for milk production. Haemonchus contortus is one of the most pathogenic parasites of small ruminants and can quickly develop AR. Thus, immediate action should be taken to slow the further spread of AR in this and other roundworm species of ruminants in Austria. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.